Canary's staked Injective ETF launches on Nasdaq, offering direct exposure to staking rewards through a regulated vehicle.
Tech & Launches ·
Canary's staked Injective ETF has begun trading on Nasdaq, providing investors with regulated exposure to Injective staking rewards through a traditional exchange-listed vehicle. The product trades under ticker INJC and represents a milestone in institutional access to crypto-native yield mechanisms.
The ETF structure allows holders to gain exposure to staking rewards without managing tokens directly or running validator infrastructure. An Injective affiliate recently registered as an SEC-recognized transfer agent, enabling custody and transfer functions necessary for a regulated fund offering. This development aligns with broader efforts to integrate blockchain assets into traditional financial rails.
The launch follows growing institutional appetite for yield-bearing crypto products. Key questions remain around fund inflows, expense ratios, and whether similar staking ETFs for other Layer 1 chains will follow.